Across TCGA pan-cancer cohorts, FAM180B mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated FAM180B data layer compared with 23 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher FAM180B mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated FAM180B expression acts as an unfavorable survival marker, although some lineages such as LUAD show a favorable association.

LUAD and LSCC are the cancer types where FAM180B mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	III,IV	1.000	0.199	.018	4	view →
LSCC	DFS	Quartile	II,III,IV	0.576	1.000	.043	2	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: FAM180B tumor-vs-normal RNA expression · all FAM180B data types